作为一种络合物应用后Sn2+的分布情况（作者译）
[The distribution of Sn2+ after application as a complex (author's transl)].
作者信息
Grimm W, Kutzner J, Kaufmann A, Stelzer U
出版信息
Rofo. 1975 Oct;123(4):318-20. doi: 10.1055/s-0029-1230205.
PMID:174980
Abstract
On animal experiments was shown that Sn2+ after i.v. application with 113Sn as radioactiv indicator was deposited in the skeleton. Experiments were done with citrat-, tartrat-, pyrophosphat-, phosphat- and Sn2+/HCl-complexes. The importance of the results for the use of Sn2+-solutions in Nuclear Medicine for men are discussed.
摘要
动物实验表明，以113Sn作为放射性指示剂静脉注射后，Sn2+沉积在骨骼中。对柠檬酸盐、酒石酸盐、焦磷酸盐、磷酸盐和Sn2+/HCl络合物进行了实验。讨论了这些结果对Sn2+溶液在核医学中用于人体的重要性。
相似文献
1
[The distribution of Sn2+ after application as a complex (author's transl)].作为一种络合物应用后Sn2+的分布情况（作者译）
Rofo. 1975 Oct;123(4):318-20. doi: 10.1055/s-0029-1230205.
2
[Resorption and excretion of tin following parenteral use of 113Sn].[经肠胃外途径使用¹¹³锡后锡的吸收与排泄]
Nucl Med (Stuttg). 1974 Jan 15;12(4):320-7.
3
Tin-117m: production, chemistry and evaluation as a bone-scanning agent.锡-117m：作为骨扫描剂的制备、化学性质及评估
Int J Appl Radiat Isot. 1973 Jun;24(6):319-25. doi: 10.1016/0020-708x(73)90072-0.
4
Metabolism and toxicity of tetravalent tin after intravenous administration to rats.四价锡静脉注射给大鼠后的代谢与毒性
Acta Physiol Pol. 1981 Nov-Dec;32(6):719-28.
5
Absorption, distribution and excretion of inorganic tin in rats.大鼠体内无机锡的吸收、分布与排泄
Toxicol Appl Pharmacol. 1974 Feb;27(2):366-79. doi: 10.1016/0041-008x(74)90208-7.
6
7
[Studies on absorption and secretion of tin following oral administration of 113 Sn].[口服¹¹³锡后锡的吸收与分泌研究]
Nucl Med (Stuttg). 1971 Oct 30;10(3):286-97.
8
[Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
Med Radiol (Mosk). 1980 Sep;25(9):9-13.
9
Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.螯合磷酸盐化合物对还原态锝和锡（II）的络合作用。I. 锝的化学状态
Nuklearmedizin. 1979 May;18(2):98-104.
Zotero 插件